Centessa Pharmaceuticals plc (LON:0ACX)
London
· Delayed Price · Currency is GBP · Price in USD 16.29
-0.46 (-2.77%)
At close: Feb 19, 2025
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 76 employees as of December 31, 2023. The number of employees decreased by 7 or -8.43% compared to the previous year.
Employees
76
Change (1Y)
-7
Growth (1Y)
-8.43%
Revenue / Employee
68.17K GBP
Profits / Employee
-1.60M GBP
Market Cap
1.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 89,900 |
| Shell | 103,000 |
| HSBC Holdings | 220,861 |
| Unilever | 128,377 |
| Rio Tinto Group | 57,000 |
| RELX PLC | 36,400 |
| BP p.l.c. | 87,800 |
| British American Tobacco p.l.c. | 46,725 |
Centessa Pharmaceuticals News
- 25 days ago - Insider Sell: Gregory Weinhoff Sells Shares of Centessa Pharmaceuticals PLC - GuruFocus
- 6 weeks ago - Centessa Pharmaceuticals names Stephen Kanes as chief medical officer - Seeking Alpha
- 6 weeks ago - Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring - Seeking Alpha
- 2 months ago - Centessa: Shift In Focus With ORX750 Development Continues To Pay Off - Seeking Alpha
- 3 months ago - Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewsWire
- 5 months ago - Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) - GlobeNewsWire
- 5 months ago - Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares - GlobeNewsWire